Efeito imunomodulatório in vivo e in vitro do oligodeoxinucleotídeo CpG na imunização com ovalbumina em camundongos nas fases neonatal e adulta. / In vivo and in vitro immunomodulatory effect of CpG-containing oligodeoxynucleotide in ovalbumin immunization of newborn and adult mice.
AUTOR(ES)
Cyro Alves de Brito
DATA DE PUBLICAÇÃO
2009
RESUMO
The allergy development may occur in the early life, during the pregnancy or postnatally at the first months of life. In mice, it is described a predisposition to Th2 biased response in the neonatal period, favoring the development of allergic response. The maturation of functions related to Th1 response by the use of immune adjuvants may be beneficial to the allergy prophylaxis. In this work, we evaluated the effect of CpGcontaining oligodeoxynucleotides (CpG-ODN) in the neonatal and adult immunization with ovalbumin (OVA) or the extract of house dust mite Blomia tropicalis (Bt). The results show CpG-ODN is able to decrease IgE antibody production, an isotype related to Th2 response, and increase IgG2a antibody levels in OVA or Bt immunization of A/Sn mice, even when mice were co-immunized with both allergens. Moreover, CpG-ODN association in neonate immunization with OVA increases in vitro IFN-g production and decreases IL-10. Comparing the modulatory efficiency of CpG in OVA immunization of neonate and adult mice, we observed a stronger effect on antibody production in adults. Results show that B cells from young mice do not increase the TLR-9 expression upon CpG stimulation for 72 hours whereas the increase of TLR-9 in adult B cells occurs within 48 hours. Besides the lower B cell activation, we found a significant increase of IL-10 and MCP-1 secretion levels by the neonatal cells stimulated by CpG. When we evaluated the influence of CpG on CD4+ T cell activation upon antigenic stimulation, we verified an upregulation of B7 molecules expression on neonate cells than adult cells. This high expression was inhibited by the addition of CpG in the culture. The induction of regulatory T cells (CD4+CD25+Foxp3+) in vitro was also suppressed by CpG. Our results show a modulatory potential of CpG in the immune response to OVA and Bt in both neonatal and adult periods. We also evidenced qualitative and quantitative differences in the CpG effect between neonates and adults. Considering the susceptibility to infections and allergy development in newborns, it becomes important to establish immunomodulatory strategies that enhance innate and adaptive responses and are prophylactic to the development of allergic disorders.
ASSUNTO(S)
hipersensibilidade immune adjuvants neonatologia adjuvantes imunológicos immune receptors receptores imunológicos neonatology hypersensitivity
Documentos Relacionados
- Imunização de camundongos com antígenos de lisado total (NLA) e de excreção-secreção (NcESA) de Neospora caninum associados com oligodeoxinucleotídeo CpG como adjuvante
- Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cells
- Efeito imunomodulatório do resveratrol em células do sistema imune in vitro e na administração via oral de ovalbumina em camundongos
- The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation
- CpG-Containing Oligonucleotides Are Efficient Adjuvants for Induction of Protective Antiviral Immune Responses with T-Cell Peptide Vaccines